Michael “Mick” Farrell became Chief Executive Officer of ResMed in March 2013. Mr Farrell served as the company’s President – Americas from May 2011 to March 2013. He was previously Senior Vice President, Strategic Business Unit – Sleep from July 2007 to May 2011, and before that he held various senior roles in marketing and business development.
Before joining ResMed in September 2000, Mr Farrell worked in management consulting and biotechnology, as well as in chemicals and steel manufacturing at Arthur D Little, Genzyme Corporation, The Dow Chemical Company, and BHP Billiton.
Mr Farrell sits on the ResMed board of directors and on the board of directors of the Medical Device Manufacturers’ Association, the California Healthcare Institute, the La Jolla Playhouse, and the New Children’s Museum in San Diego, California. Mr Farrell holds a Bachelor of Engineering, with first-class honors, from the University of New South Wales, a Master of Science in Chemical Engineering from the Massachusetts Institute of Technology, and an MBA from the MIT Sloan School of Management.